{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:29:42Z","timestamp":1792704582505,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100016981","name":"Necmettin Erbakan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179010","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:31:18Z","timestamp":1779838278000},"page":"179010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clozapine-Induced parotid inflammation and the effect of N-Acetyl cysteine on it: An experimental study"],"prefix":"10.1016","volume":"1029","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3820-4407","authenticated-orcid":false,"given":"Zakire K\u00fcbra","family":"Aksoy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pembe","family":"Oltulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpaslan","family":"\u00d6zk\u00fcrk\u00e7\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Sinan","family":"\u0130yisoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan H\u00fcseyin","family":"Kozak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179010_bib1","first-page":"253","article-title":"Brain oxidative stress and neurodegeneration in the ketamine model of schizophrenia during antipsychotic treatment: effects of N-acetylcysteine treatment","volume":"6","author":"Abdel-Salam","year":"2018","journal-title":"React Oxygen Species"},{"key":"10.1016\/j.ejphar.2026.179010_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cbi.2014.03.012","article-title":"Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage","volume":"216","author":"Abdel-Wahab","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.179010_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173645","article-title":"The role of vimentin, Connexin-43 proteins, and oxidative stress in the protective effect of propranolol against clozapine-induced myocarditis and apoptosis in rats","volume":"890","author":"Abdel-Wahab","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2026.179010_bib2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.toxrep.2014.11.012","article-title":"Clozapine-induced cardiotoxicity in rats: involvement of tumour necrosis factor alpha, NF-\u03ba\u03b2 and caspase-3","volume":"1","author":"Abdel-Wahab","year":"2014","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.ejphar.2026.179010_bib5","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22f14664","article-title":"Antipsychotic augmentation with N-acetylcysteine for patients with schizophrenia: a meta-analysis","volume":"83","author":"Andrade","year":"2022","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib6","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/0006-3223(95)00296-0","article-title":"Salivary flow-rate and composition in schizophrenic patients on clozapine: subjective reports and laboratory data","volume":"39","author":"Ben-Aryeh","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","article-title":"N-acetylcysteine as a glutathione precursor for schizophrenia\u2014a double blind, randomized, placebo controlled trial","volume":"64","author":"Berk","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1176\/ajp.153.3.445a","article-title":"Treatment of clozapine-induced parotid gland swelling","volume":"153","author":"Brodkin","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib9","article-title":"Could N-acetylcysteine improve the safety of clozapine?","volume":"e2769","author":"Chr\u00e9tien","year":"2020","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179010_bib10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1345\/aph.19259","article-title":"Clozapine-induced hypersalivation","volume":"34","author":"Davydov","year":"2000","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179010_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/a-1625-6388","article-title":"An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels","volume":"55","author":"de Leon","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1124\/jpet.120.000164","article-title":"Association between N-desmethylclozapine and clozapine-induced sialorrhea: involvement of increased nocturnal salivary secretion via muscarinic receptors","volume":"375","author":"Ishikawa","year":"2020","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179010_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.4103\/0019-5545.171849","article-title":"Clozapine induced eosinophilia: an often neglected important adverse effect","volume":"57","author":"Kadiyala","year":"2015","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.26650\/experimed.2021.926862","article-title":"Oxidative stress markers in young patients with acute myocardial infarction and their correlation with cardiac enzymes","volume":"11","author":"Karabulut","year":"2021","journal-title":"Experimed"},{"key":"10.1016\/j.ejphar.2026.179010_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00213-005-0248-4","article-title":"Clozapine-induced sialorrhea: pathophysiology and management strategies","volume":"185","author":"Kumar","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2026.179010_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/JCP.0000000000001079","article-title":"Rechallenge following clozapine-associated eosinophilia: a case report and literature review","volume":"39","author":"Lally","year":"2019","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179010_bib17","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/a-0991-7684","article-title":"Clozapine disrupts endothelial nitric oxide signaling and antioxidant system for its cardiovascular complications","volume":"69","author":"Nair","year":"2019","journal-title":"Drug Res."},{"key":"10.1016\/j.ejphar.2026.179010_bib18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/schbul\/sbac065","article-title":"N-acetylcysteine in schizophrenia resistant to clozapine: a double blind randomized placebo controlled trial targeting negative symptoms","volume":"48","author":"Neill","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ejphar.2026.179010_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2019.112491","article-title":"Clozapine and cardiotoxicity \u2013 a guide for psychiatrists written by cardiologists","volume":"282","author":"Patel","year":"2019","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.179010_bib20","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/070674370705200607","article-title":"Clozapine-induced hypersalivation: a review of treatment strategies","volume":"52","author":"Sockalingam","year":"2007","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.ejphar.2026.179010_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(99)00116-4","article-title":"Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist","volume":"42","author":"Song","year":"2000","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2026.179010_bib22","article-title":"Pharmacological interventions for clozapine-induced hypersalivation","volume":"3","author":"Syed","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2026.179010_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S2215-0366(22)00044-X","article-title":"Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in Finland","volume":"9","author":"Tiihonen","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.14748\/ssm.v50i2.5011","article-title":"Transient parotitis in the course of clozapine treatment: a case report and review of the literature","volume":"50","author":"Todorova-Nenova","year":"2018","journal-title":"Scripta Scientifica Medica"},{"key":"10.1016\/j.ejphar.2026.179010_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00212-2","article-title":"Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials","volume":"56","author":"Tuunainen","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.ejphar.2026.179010_bib26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/YIC.0000000000000297","article-title":"Effect of N-acetylcysteine on clozapine-induced sialorrhea in schizophrenic patients: a case series","volume":"35","author":"Uzun","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179010_bib27","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/ccr3.2431","article-title":"The sublingual use of atropine in the treatment of clozapine-induced sialorrhea: a systematic review","volume":"7","author":"Van der Poorten","year":"2019","journal-title":"Clin. Case Rep."},{"key":"10.1016\/j.ejphar.2026.179010_bib28","first-page":"115","article-title":"Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis","volume":"322","author":"Wagner","year":"2025","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.ejphar.2026.179010_bib29","first-page":"1","article-title":"Multidisciplinary consensus on prevention, screening and monitoring of clozapine-associated myocarditis and clozapine rechallenge after myocarditis","author":"Wagner","year":"2025","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ejphar.2026.179010_bib30","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(24)37177-0","article-title":"Neutrophil cytotoxicity of clozapine metabolites: possible role in agranulocytosis","volume":"283","author":"Williams","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:14:05Z","timestamp":1784808845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926004929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S0014299926004929"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine-Induced parotid inflammation and the effect of N-Acetyl cysteine on it: An experimental study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179010"}}